AKT1 and cancer: Studies have shown that, in cancers, the PI3K/Akt signaling pathway affects the cell cycle by phosphorylating cyclin-dependent kinase inhibitors and preventing translocation to the nucleus of the tumor suppressor gene p27, thereby attenuating its inhibitory effect on the cell cycle and directly promoting tumor cell proliferation [151].